About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« A Scientist's Resolutions | Main | Pemoline Problems »

January 3, 2006

Comments Welcome - Really

Email This Entry

Posted by Derek

Over the last month or so, the commenting system here has been rather erratic. Despite having Movable Type set to allow anyone to comment, people keep getting "held for moderation" messages - it happens to me, too. At the same time, an increasing amount of junk is making its way through. I'm going in manually every so often to clean out the stables, but that's not the best solution. My intention is to let anyone comment at any time, except the people who are robotically offering us all opportunities to play poker or to all-naturally extend various organs of our bodies. Anyone with experience in dealing with MT's current treatment of junk comments is welcome to offer suggestions on how to fix things.

I should also mention that Corante is going to be trying some server migrations, probably starting this coming weekend. The hope is that posting on this and the other blogs won't be disrupted, but if there's an outage, that'll be the reason. . .

Comments (2) + TrackBacks (0) | Category: Blog Housekeeping


1. Milo on January 3, 2006 11:28 AM writes...

I have no clue how to implement this, but you could try using the "word verification" type of system. Here is an example.

Permalink to Comment

2. michael haase on January 22, 2006 3:06 AM writes...

why is this guy still doing infomerials here it is 1/22/06 sunday morning and he is still on t.v. selling his crap and our government agencys are not doing any thing to to stop him since he is not suppose to to sell this book any more I guess my 20 year in law enforcement was wasted....... I hope that People like this would be put in jail forever so not to take advantage of desperate people. thank you for your time Lt. Detective Michael Haase

Permalink to Comment


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry